NTx co-founder featured by Times Higher Education
Tim Witney featured in their spotlight guide 'A step-by-step guide to commercialising your research'
World Cancer Day 2026
King's College London sat down with our CSO, Prof. Tim Witney, for World Cancer Day.
Latest press release
Read our press release detailing the conclusion of our recent funding round.
Launch announcement
Nuclide Therapeutics secures £5 million investment to spearhead first-in-human clinical trials.
